TGTX: TG Therapeutics Inc. Stocks News on November 17, 2024

TGTX

Argus Research

5 days ago

TGTX: Raising target price to $32.00

Exploring 3 High Growth Tech Stocks in the United States

TGTX

Simply Wall St.

5 days ago

Exploring 3 High Growth Tech Stocks in the United States

TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

TGTX

Simply Wall St.

10 days ago

TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

TGTX

Argus Research

12 days ago

TGTX: Rating decreased to a HOLD

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TGTX

Simply Wall St.

12 days ago

TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TGTX

GuruFocus.com

13 days ago

TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

TGTX

Thomson Reuters StreetEvents

13 days ago

Q3 2024 TG Therapeutics Inc Earnings Call

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations

TGTX

Investor's Business Daily

13 days ago

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations

TGTX

MT Newswires

13 days ago

Sector Update: Health Care Stocks Mixed Premarket Monday

TGTX

Zacks

13 days ago

TG Therapeutics (TGTX) Lags Q3 Earnings Estimates

AI Stocks Meta, Oracle Lead Five Names Near Buy Points

TGTX

Investor's Business Daily

15 days ago

AI Stocks Meta, Oracle Lead Five Names Near Buy Points

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

TGTX

GlobeNewswire

16 days ago

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

TGTX

Insider Monkey

17 days ago

Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?

High Growth Tech Stocks to Watch in October 2024

TGTX

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in October 2024

TGTX

Argus Research

a month ago

TGTX: Lowering target price to $23.00

TGTX

Insider Monkey

2 months ago

TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish

TGTX

Simply Wall St.

2 months ago

Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock?

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)

TGTX

Investor's Business Daily

2 months ago

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)

TGTX

MT Newswires

2 months ago

Sector Update: Health Care Stocks Steady Premarket Wednesday

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug

TGTX

Investor's Business Daily

2 months ago

IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug

TGTX

MT Newswires

2 months ago

TG Therapeutics Reports 30-Minute BRIUMVI Infusions Well Tolerated in Relapsing Multiple Sclerosis Trial

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

TGTX

GlobeNewswire

2 months ago

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

TGTX

GlobeNewswire

2 months ago

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

TGTX

PR Newswire

2 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

TGTX

Investor's Business Daily

2 months ago

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

TGTX

GlobeNewswire

2 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

TGTX

Insider Monkey

3 months ago

TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory

High Growth Tech Stocks in the United States to Watch

TGTX

Simply Wall St.

3 months ago

High Growth Tech Stocks in the United States to Watch

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter

TGTX

Investor's Business Daily

3 months ago

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability

TGTX

Investor's Business Daily

3 months ago

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability

FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment

TGTX

Clinical Trials Arena

3 months ago

FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment

Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit

TGTX

Simply Wall St.

3 months ago

Results: TG Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit

TGTX

MT Newswires

3 months ago

B. Riley Adjusts Target on TG Therapeutics to $34 From $29, Maintains Buy Rating

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%

TGTX

Investor's Business Daily

3 months ago

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%

TGTX

MT Newswires

3 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

TGTX

MT Newswires

3 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

TGTX

MT Newswires

3 months ago

Sector Update: Health Care

TGTX

MT Newswires

3 months ago

TG Therapeutics Shares Rally After Swinging to Surprise Q2 Profit, Revenue Surges; Boosts Full-Year Outlook for Briumvi Sales

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%

TGTX

Investor's Business Daily

3 months ago

TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157%

TGTX

Zacks

3 months ago

TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates

TGTX

Associated Press Finance

3 months ago

TG Therapeutics: Q2 Earnings Snapshot

TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance

TGTX

GlobeNewswire

3 months ago

TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance

TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

TGTX

GlobeNewswire

3 months ago

TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

TGTX

Simply Wall St.

4 months ago

TG Therapeutics, Inc.'s (NASDAQ:TGTX) recent 3.1% pullback adds to one-year year losses, institutional owners may take drastic measures

Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves

TGTX

Investor's Business Daily

4 months ago

Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves

Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area

TGTX

Investor's Business Daily

5 months ago

Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area

TGTX

GuruFocus.com

5 months ago

Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)

Italian energy company targets Britain for fleet of 20 mini-nukes

TGTX

The Telegraph

5 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

TGTX

Motley Fool

5 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

TGTX

AFP

5 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

TGTX

Simply Wall St.

5 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

TGTX

Simply Wall St.

5 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

TGTX

Simply Wall St.

5 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

TGTX

Simply Wall St.

5 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

TGTX

Motley Fool

5 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

TGTX

GlobeNewswire

5 months ago

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

TGTX

GlobeNewswire

5 months ago

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

TGTX

GlobeNewswire

6 months ago

TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

TGTX

Simply Wall St.

6 months ago

Despite shrinking by US$192m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 131% over 5 years

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

TGTX

GlobeNewswire

6 months ago

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

TGTX

Insider Monkey

6 months ago

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript

TGTX

Simply Wall St.

6 months ago

Rainbows and Unicorns: TG Therapeutics, Inc. (NASDAQ:TGTX) Analysts Just Became A Lot More Optimistic

Why TG Therapeutics Stock Was Rocketing Higher This Week

TGTX

Motley Fool

6 months ago

Why TG Therapeutics Stock Was Rocketing Higher This Week

TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TGTX

Simply Wall St.

7 months ago

TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

TGTX

GuruFocus.com

7 months ago

TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...

TGTX

Thomson Reuters StreetEvents

7 months ago

Q1 2024 TG Therapeutics Inc Earnings Call

TGTX

GuruFocus.com

7 months ago

TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss

TGTX

Zacks

7 months ago

TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates

TGTX

Associated Press Finance

7 months ago

TG Therapeutics: Q1 Earnings Snapshot

TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

TGTX

GlobeNewswire

7 months ago

TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

TGTX

GlobeNewswire

7 months ago

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

TGTX

Zacks

7 months ago

After Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TGTX

GlobeNewswire

7 months ago

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

TGTX

GlobeNewswire

7 months ago

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TGTX

GlobeNewswire

7 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TGTX

Simply Wall St.

8 months ago

Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?

TGTX

Insider Monkey

8 months ago

13 Best Biotech Stocks To Buy Under $20

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TGTX

GlobeNewswire

8 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TGTX

GlobeNewswire

9 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TGTX

Insider Monkey

9 months ago

TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript

TGTX

Thomson Reuters StreetEvents

9 months ago

Q4 2023 TG Therapeutics Inc Earnings Call

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?

TGTX

Investor's Business Daily

9 months ago

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?

TGTX

Zacks

9 months ago

TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates

TGTX

GuruFocus.com

9 months ago

TG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results

TGTX

Associated Press Finance

9 months ago

TG Therapeutics: Q4 Earnings Snapshot

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

TGTX

GlobeNewswire

9 months ago

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)

TGTX

GlobeNewswire

9 months ago

TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)

TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)

TGTX

GlobeNewswire

9 months ago

TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

TGTX

GlobeNewswire

9 months ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update

TGTX

Simply Wall St.

9 months ago

Institutional owners may take dramatic actions as TG Therapeutics, Inc.'s (NASDAQ:TGTX) recent 6.8% drop adds to one-year losses

TGTX

Zacks

9 months ago

Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TGTX

GlobeNewswire

9 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Progress Chief Inclusion and Diversity Officer Selected as a Keynote Speaker for Bulgaria’s Academy for Diversity, Equity and Inclusion

TGTX

GlobeNewswire

10 months ago

Progress Chief Inclusion and Diversity Officer Selected as a Keynote Speaker for Bulgaria’s Academy for Diversity, Equity and Inclusion

Ermenegildo Zegna Group Ends Full Year 2023 on a Strong Note With Accelerated Growth in the Fourth Quarter

TGTX

Business Wire

10 months ago

Ermenegildo Zegna Group Ends Full Year 2023 on a Strong Note With Accelerated Growth in the Fourth Quarter

TGTX

Business Wire

10 months ago

Papa Johns Declares Quarterly Dividend

TGTX

GlobeNewswire

10 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

TGTX

CNW Group

10 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

TGTX

Business Wire

10 months ago

Form 8.3 - DX (Group) plc

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

TGTX

GlobeNewswire

10 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

TGTX

GlobeNewswire

10 months ago

Latest TG Therapeutics Inc. (TGTX) News on November 17, 2024

Share on Social Networks: